In the quest for high-quality deals that are convincing enough for banks to back and make investors excited about the coming fundraising round, Nordic players have looked towards infrastructure.
BPI, Hi Inov and Aurinvest renewed their support for the Parisian group as part of the investment round
Developer of sickle cell disease treatments recently rebranded from Dilaforette and announced intention to float
Transaction marks the fourth bolt-on completed by CLS with Ardian's support
Merete Haukås and Johan Nord join the rank of partners at Norway-based Cubera Private Equity